RESEARCH-USE BIOSIMILAR ANTIBODY
Racotumomab
Monoclonal antibody · IgG1
Racotumomab (Anti-Human NGcGM3 Recombinant Antibody) is an anti-idiotype monoclonal antibody (MAb). Racotumomab reacts to Neu-glycolyl (NeuGc)-containing gangliosides, sulfatides, and other antigens expressed in tumors. Racotumomab is an active anticancer agent for lung cancer.
TARGETIdiotope of anti-NeuGc-ganliosides
YMonoclonal antibody
CATALOGSC-BS-242
CATALOG NUMBERSC-BS-242
MOLECULAR WEIGHTApprox. 145.5 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Racotumomab (Anti-Human NGcGM3 Recombinant Antibody) is an anti-idiotype monoclonal antibody (MAb). Racotumomab reacts to Neu-glycolyl (NeuGc)-containing gangliosides, sulfatides, and other antigens expressed in tumors. Racotumomab is an active anticancer agent for lung cancer.
Racotumomab is a recombinant research-use antibody directed against Idiotope of anti-NeuGc-ganliosides.